Cite

    Wei, J. C., Baeten, D., Geusens, P., Porter, B., Martin, R., & Richards, H. (n.d.). aB0742 Intravenous Loading and Subcutaneous Maintenance with Secukinumab Provides Sustained Improvement in Multiple Measures of Disease Activity in Subjects with Active Ankylosing Spondylitis: 52-Week Data From the Randomized, Double-Blind, Placebo-Controlled, Phase 3 Measure 1 Study. Annals of the rheumatic diseases, 74, 1146–1147. http://access.bl.uk/ark:/81055/vdc_100135157040.0x000053